# Generic Ozempic South Africa: Aspen Semaglutide Approved

Source: https://www.dietglp.com/blog/generic-ozempic-south-africa/
Published: 2026-11-11
Keywords: generic ozempic south africa, aspen semaglutide, is ozempic available in south africa, generic ozempic south africa price, ozempic generic south africa, semaglutide south africa, semaglutide south africa price, generic semaglutide south africa, aspen pharmacare semaglutide, aspen semaglutide canada, generic ozempic available in south africa, ozempic generic name south africa, ozempic south africa price, semaglutide generics south africa

**TL;DR:** Generic Ozempic in South Africa now has a second approved maker. On November 11, 2026, Aspen Pharmacare said its generic semaglutide injection won regulatory approval in South Africa and Brazil, and that sales should start there and in Canada over the next few months. It is approved for adults with type 2 diabetes, not for weight loss, and Aspen has not published a price. Sun Pharma's generic was approved in South Africa in July 2026. Whichever pen you use, [Sharpy](https://apps.apple.com/us/app/glp-diet-app-sharpy/id6762084138) gives you a daily protein target and a 20-minute workout so the weight you lose is fat, not muscle.

Is there a generic Ozempic in South Africa yet? **Yes, and the list just grew. On November 11, 2026, Aspen Pharmacare said its generic semaglutide injection won regulatory approval in South Africa and Brazil.** Aspen is South Africa's biggest drugmaker. It expects to start selling in South Africa, Brazil and Canada over the next few months. The product is approved for adults with type 2 diabetes, not for weight loss, and no price has been published.

Here is what was approved, what is still unknown, and what it means if you take semaglutide.

## What is Aspen semaglutide?

Semaglutide is the active drug in Ozempic and Wegovy, both made by Novo Nordisk. A generic is a copy of a brand drug that a regulator has judged to work the same way. Aspen's version is a generic semaglutide injection. In Canada it is registered under the name Aspen-Semaglutide. Aspen has not said what name will be on the South African box.

Aspen says its semaglutide is approved, together with diet and exercise, to improve blood sugar control in adults with type 2 diabetes. That is the Ozempic use. It is not the Wegovy use, which is weight management.

## Generic Ozempic South Africa: what is approved so far

| Product | Maker | South Africa status | Approved for | Price |
|---|---|---|---|---|
| Ozempic (brand) | Novo Nordisk | Sold on prescription | Adults with type 2 diabetes | Set by single exit price |
| Generic semaglutide pen, 2 mg and 4 mg | Sun Pharma (India) | Approval reported July 15, 2026 | Adults with type 2 diabetes that is not well controlled | Not stated in the approval news |
| Generic semaglutide injection | Aspen Pharmacare (South Africa) | Approval announced November 11, 2026; launch expected in the coming months | Adults with type 2 diabetes | Not published |
| Wegovy (brand) | Novo Nordisk | Sold on prescription | Weight management | About R1,873 to R3,746 a month by dose, per Reuters in March 2026 |

South Africa's medicines regulator is SAHPRA. Novo Nordisk's semaglutide patent there expired in March 2026, according to Reuters. That is why copies are arriving now. More may follow. Aspen itself is waiting on approval in about 20 countries, chief executive Stephen Saad told Business Day.

## Is Ozempic available in South Africa?

Yes. Brand Ozempic is sold in South Africa on prescription for adults with type 2 diabetes. Wegovy is sold there too, and so is Mounjaro (tirzepatide) from Eli Lilly, which Aspen distributes across sub-Saharan Africa.

Mounjaro is the market leader. Aspen says South African sales of GLP-1 medicines have grown to nearly R3 billion, about $182 million, and that Mounjaro makes up more than half. Aspen does not expect its generic to slow Mounjaro sales. Our [Mounjaro guide](/blog/mounjaro-guide/) explains how that drug differs from semaglutide.

## When will Aspen semaglutide be on shelves?

Aspen has given a window, not a date: "over the next few months" for Canada, Brazil and South Africa.

- **South Africa:** approved, launch date not announced.
- **Brazil:** approved, launch date not announced. Aspen said in September that it buys the active ingredient for Brazil from a different supplier than for Canada.
- **Canada:** Health Canada approved Aspen-Semaglutide for type 2 diabetes in July 2026. The launch was held up while Aspen waited for the active ingredient from Dr. Reddy's Laboratories.

Earlier in 2026, Aspen said its South African plant would make multi-dose pens and its French plant would make single-dose autoinjectors. Which pen and which strengths reach South African pharmacies first has not been announced.

An approval does not put stock in your pharmacy. If you want the generic, ask your pharmacist what is actually available, and ask your doctor before any switch.

## Generic Ozempic South Africa price: what we know

Short answer: there is no Aspen price yet.

What we do know:

1. **A general promise.** In September 2026, Saad said generic GLP-1 medicines could cost at least 50% less than the brands. He was talking about generics in general. It is not a price for this pen.
2. **How prices work.** In South Africa, each medicine has a single exit price, the most a maker may charge. Pharmacies add a regulated dispensing fee. Your pharmacist can look up the current figure for any registered pen.
3. **Brand prices are already falling.** Novo Nordisk cut Wegovy's South African price twice. Reuters reported in March 2026 that the lowest dose dropped from R3,090 to R1,873 a month and the highest dose fell to R3,746.
4. **Medical aid.** Aspen has said it is in talks with medical schemes. Whether your scheme pays depends on your plan and your diagnosis.

Be careful with websites that quote an exact Aspen price today. None has been announced.

## Can you use generic Ozempic for weight loss?

The Aspen and Sun Pharma generics are approved for type 2 diabetes. Semaglutide for weight management is approved under the Wegovy brand, at a different top dose. A doctor may prescribe a medicine off-label, but that is their call, not something to arrange on your own. Our guide to [GLP-1 off-label use](/blog/glp-1-off-label-use/) explains what that means, and [Wegovy vs Ozempic](/blog/wegovy-vs-ozempic/) shows how the two brands differ.

One warning matters more as demand grows. A registered generic is not the same as a compounded or unregistered product sold online. Only a pen that the regulator has approved, dispensed by a pharmacy on a prescription, has been checked for quality. Our [compounded GLP-1 guide](/blog/compounded-glp1/) covers the difference.

## A cheaper pen does not protect your muscle

A generic changes the bill. It does not change what semaglutide does in your body. You eat less, and if protein and strength work drop too, part of the weight you lose can be muscle. [Sharpy](https://apps.apple.com/us/app/glp-diet-app-sharpy/id6762084138) sets one daily protein target from your body weight and gives you one 20-minute strength workout a day, so more of the loss is fat. See our [protein target guide](/blog/protein-target-on-glp1/) for the numbers.

## Aspen semaglutide in Brazil and Canada

Brazil now has at least three approved generic semaglutide injections: Owozy from Sandoz and Adalvo (July 29, 2026), [Dr. Reddy's semaglutide](/blog/dr-reddys-semaglutide/) (November 5, 2026) and Aspen's (announced November 11, 2026). Canada has several on sale already. Our [generic semaglutide guide](/blog/generic-semaglutide/) tracks every country, including why the United States is still waiting.

## What we still do not know

- The South African brand name, pen type and strengths of Aspen's product.
- The price, and whether it will undercut Sun Pharma's generic.
- The exact launch date in each country.
- Which medical schemes will cover it.

We will update this guide when Aspen confirms them.

## The bottom line

South Africa now has two approved generic versions of Ozempic, from Sun Pharma and Aspen. Aspen's was announced on November 11, 2026, is approved for type 2 diabetes only, and should reach pharmacies in the coming months at a price that is still unknown. Do not switch or start on your own. Ask your doctor and pharmacist. And whatever semaglutide you take, keep your muscle with [Sharpy](https://apps.apple.com/us/app/glp-diet-app-sharpy/id6762084138): one protein target, one 20-minute workout and one Shape Score a day.

## Sources

- [Reuters via SRN News: Aspen Pharmacare wins approval for generic semaglutide in Brazil, South Africa (November 11, 2026)](https://srnnews.com/aspen-pharmacare-wins-approval-for-generic-semaglutide-in-brazil-south-africa/)
- [Business Day: Aspen gets regulatory nod in Brazil and SA for generic injectable semaglutide (November 11, 2026)](https://www.businessday.co.za/companies/company-strategy/2026-11-11-aspen-gets-regulatory-nod-in-brazil-and-sa-for-generic-injectable-semaglutide/)
- [BNN Bloomberg: Aspen Pharmacare wins Canada approval for generic Ozempic (July 20, 2026)](https://www.bnnbloomberg.ca/business/2026/07/20/aspen-pharmacare-wins-canada-approval-for-generic-ozempic-after-novo-patent-expiry/)
- [Business Day: Sun Pharma wins South Africa approval to launch generic Ozempic (July 15, 2026)](https://www.businessday.co.za/companies/2026-07-15-indias-sun-pharma-wins-south-africa-approval-to-launch-generic-ozempic/)
- [Business Day: Aspen profit jumps on Mounjaro demand (September 2, 2026)](https://www.businessday.co.za/companies/2026-09-02-aspen-profit-jumps-on-mounjaro-demand/)
- [MoneyWeb via FOODStuff SA: Aspen bets big on weight-loss drugs (September 4, 2026)](https://www.foodstuffsa.co.za/aspen-bets-big-on-weight-loss-drugs-as-glp-1-demand-explodes/)
- [Reuters via Business Recorder: Novo Nordisk cuts Wegovy price in South Africa for a second time (March 2026)](https://www.brecorder.com/news/40413337)


## Frequently asked questions

**Q: Is there a generic Ozempic in South Africa?**

A: Yes. Sun Pharma won South African approval for a generic semaglutide pen in July 2026, and Aspen Pharmacare said on November 11, 2026 that its generic semaglutide injection is approved too. Both are approved for adults with type 2 diabetes.

**Q: Is Ozempic available in South Africa?**

A: Yes. Brand Ozempic from Novo Nordisk is sold in South Africa on prescription for adults with type 2 diabetes. Wegovy, the higher-dose semaglutide brand for weight management, is sold there too. Generic semaglutide pens are now being added to that list.

**Q: When will Aspen semaglutide be available in South Africa?**

A: Aspen has not given a date. On November 11, 2026, the company said it expects to start selling in Canada, Brazil and South Africa over the next few months. Approval and pharmacy stock are different steps, so ask your pharmacist what is on the shelf.

**Q: What is the generic Ozempic South Africa price?**

A: Aspen has not published a price for its semaglutide. In September 2026, Aspen chief executive Stephen Saad said generic GLP-1 medicines could cost at least 50% less than the brands. That was a general remark, not a price list. In South Africa the legal maximum price of a medicine is its single exit price, which your pharmacist can look up.

**Q: Is Aspen semaglutide approved for weight loss?**

A: No. Aspen said the product is approved, along with diet and exercise, to improve blood sugar control in adults with type 2 diabetes. That matches Ozempic, not Wegovy. Using it for weight loss would be off-label, which is a decision for a doctor.

**Q: Is Aspen semaglutide available in Canada?**

A: It is approved but was not yet on sale as of November 11, 2026. Health Canada approved Aspen-Semaglutide for type 2 diabetes in July 2026. Aspen said the launch depended on ingredient supply from Dr. Reddy's Laboratories, and now says sales should begin in the coming months.

**Q: Can Americans buy generic Ozempic from South Africa?**

A: No generic semaglutide is approved for sale in the United States, and US rules generally do not allow people to import prescription drugs for personal use. Talk to your prescriber about approved US options and self-pay prices.

